Philips Advances Imaging and Physiology for PCI at EuroPCR 2026

At EuroPCR 2026, Royal Philips will showcase innovations in imaging, physiology, and AI-enabled guidance to address the complexities of cardiac procedures while reducing radiation exposure for patients and medical staff. The company emphasizes the integration of these technologies into a unified workflow to enhance clinical decision-making and procedural safety.